Download SmartTRAK's Perspective Article
Charlie Covert, vice president and general manager of Medtronic’s (MDT) Pain Therapies, discusses the Company’s latest research and innovation in neuromodulation from NANS 2021 in an interview with SmartTRAK. To find out about what was new for MDT at NANS 2021, including the 12-month results from MDT’s DTM SCS study, its initiatives in evoked compound action potentials (ECAPs), the Vanta recharge-free SCS and MDT’s research into expanded indications, download our PDF!
